Showing results (601-610 of 628) with videos related to
Sort By:
Pageof 63
Genes & Development|January 5, 2012
Structure and operation of the DNA-translocating type I DNA restriction enzymesChristopher K Kennaway, James E N Taylor, Chun Feng Song, et al.Journal of Chemical Information and Computer Sciences|May 1, 1997
The PRINTS database of protein fingerprints: a novel information resource for computational molecular biologyT K Attwood, H Avison, M E Beck, et al.Leukemia|July 13, 2026
Randomized phase 2 trial of CPX-351 vs. CLAG-M (cladribine, cytarabine, G-CSF, and mitoxantrone) for medically unfit adults with acute myeloid leukemia or other high-grade myeloid neoplasmsAnna B Halpern, Megan Othus, Mary-Elizabeth M Percival, et al.European Journal of Haematology|September 6, 2023
Hyper-CVAD versus dose-adjusted EPOCH as initial treatment for adults with acute lymphoblastic leukemiaLucas C Zarling, Philip A Stevenson, Lorinda A Soma, et al.Military Medicine|April 6, 2016
Economic Burden of Hearing Loss for the U.S. Military: A Proposed Framework for EstimationHasanat Alamgir, David L Tucker, Sun-Young Kim, et al.Bioorganic & Medicinal Chemistry Letters|January 14, 2009
Anthranilimide based glycogen phosphorylase inhibitors for the treatment of type 2 diabetes. Part 3: X-ray crystallographic characterization, core and urea optimization and in vivo efficacyStephen A Thomson, Pierette Banker, D Mark Bickett, et al.Journal of Medicinal Chemistry|December 4, 1998
N-(2-Benzoylphenyl)-L-tyrosine PPARgamma agonists. 3. Structure-activity relationship and optimization of the N-aryl substituentJ E Cobb, S G Blanchard, E G Boswell, et al.Military Medicine|December 4, 2014
The Department of Defense Epidemiologic and Economic Burden of Hearing Loss studySharon P Cooper, Hasanat Alamgir, Kristina W Whitworth, et al.Journal of Medicinal Chemistry|November 28, 2006
6-(4-chlorophenyl)-3-substituted-thieno[3,2-d]pyrimidin-4(3H)-one-based melanin-concentrating hormone receptor 1 antagonistFrancis X Tavares, Kamal A Al-Barazanji, Michael J Bishop, et al.Proceedings of the National Academy of Sciences of the United States of America|May 26, 1999
A peroxisome proliferator-activated receptor gamma ligand inhibits adipocyte differentiationJ L Oberfield, J L Collins, C P Holmes, et al.Pageof 63